BuyMeWhiskeyStock analysisAnswersELAN news
Home › Stock analysis › ELAN

Elanco Animal Health (ELAN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

ELAN jumps 4.4% to $23.54, a 1-month high. Closed at $23.54, +4.39% vs the prior close of $22.55. Day range $22.80–$23.79, opened at $22.83.

Last close$23.54+4.39%
Day range22.80–23.79
Open22.83
Volume6.65M
52-week range19.40–27.98
Avg volume (20d)5.43M

ELAN daily analysis — what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 — ELAN jumps 4.4% to $23.54, a 1-month high
Oct 14, 2026 — ELAN rises 0.6% to $22.55
Oct 13, 2026 — ELAN dips 0.7% to $22.41
Oct 12, 2026 — ELAN dips 1.6% to $22.56
Oct 9, 2026 — ELAN rises 1.7% to $22.92
Oct 8, 2026 — ELAN rises 0.8% to $22.54
Oct 7, 2026 — ELAN dips 0.5% to $22.36
Oct 6, 2026 — ELAN ends flat (-0.1%) to $22.48
Oct 5, 2026 — ELAN rises 1.7% to $22.51
Oct 2, 2026 — ELAN rises 1.7% to $22.14

ELAN latest news & SEC filings

Every SEC filing by or about ELAN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)

Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001969223-26-001074

Oct 6, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001916473-26-000044

Oct 6, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001479079-26-000045

Oct 6, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001724169-26-000045

Oct 1, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001679166-26-000013

Sep 22, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001479079-26-000043

Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001739104-26-000043

Aug 5, 2026 · 8-K — Current report

Current report — a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001739104-26-000040

Jul 14, 2026 · SCHEDULE 13G — Passive stake (13G)

Passive stake (13G) — an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000354204-26-000792

Things to know before you trade ELAN

ELAN market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 202622.8323.7922.8023.546.65M
Oct 14, 202622.3822.9222.2622.554.94M
Oct 13, 202622.6322.7722.2222.413.35M
Oct 12, 202622.8822.9322.5522.564.65M
Oct 9, 202622.5922.9822.4222.922.52M
Oct 8, 202622.0822.6322.0022.544.57M
Oct 7, 202622.2622.6222.1622.364.20M
Oct 6, 202622.7223.0422.2322.487.04M
Oct 5, 202622.0922.7321.7222.514.79M
Oct 2, 202622.0422.3621.7722.145.00M
Oct 1, 202622.3222.5021.6221.775.87M
Sep 30, 202622.6022.8622.3522.395.36M
Sep 29, 202622.4822.6922.1622.615.41M
Sep 28, 202622.0122.6421.9222.456.59M
Sep 25, 202622.3522.7222.1022.316.45M
Sep 24, 202622.5922.6321.7522.357.64M
Sep 23, 202622.8223.3922.5122.575.34M
Sep 22, 202622.5323.1822.5122.935.61M
Sep 21, 202622.5822.5822.1722.434.61M
Sep 18, 202622.7722.8822.2822.427.95M

About Elanco Animal Health

Elanco Animal Health (ELAN) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in INDIANAPOLIS, IN. Fiscal year ends December 31. SEC CIK 1739104.

ELAN board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Kapila K AnandDirectorJul 2, 2026
Art A GarciaDirectorMay 26, 2026
R David HooverDirectorMay 26, 2026
Michael J HarringtonDirectorAug 13, 2026
Paul HerendeenDirectorAug 10, 2026
Deborah Turner KochevarDirectorMay 26, 2026
Lawrence Erik KurziusDirectorAug 21, 2026
Stacey MaDirectorMay 26, 2026
Kirk P McdonaldDirectorMay 26, 2026
Denise Scots-KnightDirectorMay 26, 2026
Jeffrey N SimmonsPRESIDENT, CEO AND DIRECTORSep 22, 2026

Executive officers

NameTitleLatest filing
Timothy J BettingtonSEE REMARKSMar 5, 2026
Ramiro Martin CabralSEE REMARKSMar 5, 2026
De Simas Jose Manuel CorreiaSEE REMARKSMar 10, 2026
David S KinardSEE REMARKSJul 2, 2026
Grace McardleEVP, MANUFACTURING AND QUALITYMar 5, 2026
James M MeerCHIEF ACCOUNTING OFFICERMar 5, 2026
Rajeev A. ModiSEE REMARKSSep 22, 2026
Shiv O'NeillGC AND CORP SECAug 18, 2026
Jeffrey N SimmonsPRESIDENT, CEO AND DIRECTORSep 22, 2026
Robert M VanhimbergenEVP and CFOSep 22, 2026
Brabander Ellen DeSEE REMARKSApr 7, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 20, 2026Lawrence Erik KurziusBuy40,000$23.40
Aug 18, 2026Shiv O'NeillBuy3,998$23.58
Aug 12, 2026Michael J HarringtonBuy5,000$21.82
Aug 7, 2026Paul HerendeenBuy10,000$23.69
Aug 7, 2026Robert M VanhimbergenBuy4,200$23.08
May 15, 2026Rajeev A. ModiBuy4,911$20.35
May 15, 2026Jeffrey N SimmonsBuy4,971$20.09
Dec 12, 2025Lawrence Erik KurziusBuy10,000$21.30
Dec 11, 2025Rajeev A. ModiBuy4,500$21.33
Dec 11, 2025Jeffrey N SimmonsBuy22,000$21.75
Dec 11, 2025Robert M VanhimbergenBuy6,950$21.64

ELAN financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$4.71B$-232.00M-0.47$560.00M
Dec 31, 2024$4.44B$338.00M0.68$541.00M
Dec 31, 2023$4.42B$-1.23B-2.50$271.00M
Dec 31, 2022$4.41B$-78.00M-0.16$452.00M
Dec 31, 2021$4.76B$-483.00M-0.99$483.00M

Latest balance sheet: total assets $13.56B, total liabilities $6.97B, cash $530.00M (as of Jun 30, 2026).

ELAN earnings / results-day log

DateFilingClose that day
Aug 5, 20268-K Item 2.02 (results)$26.22
May 6, 20268-K Item 2.02 (results)$26.18
Feb 24, 20268-K Item 2.02 (results)$26.38
Nov 5, 20258-K Item 2.02 (results)$21.60
Aug 7, 20258-K Item 2.02 (results)$16.48
May 7, 20258-K Item 2.02 (results)$12.01
Feb 25, 20258-K Item 2.02 (results)$10.70
Nov 7, 20248-K Item 2.02 (results)$14.50
Aug 8, 20248-K Item 2.02 (results)—
May 8, 20248-K Item 2.02 (results)—
Feb 26, 20248-K Item 2.02 (results)—
Nov 7, 20238-K Item 2.02 (results)—

Related stocks · Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on ELAN

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.